Literature DB >> 6221839

In situ demonstration of T lymphocyte subsets in granulomatous inflammation: leprosy, rhinoscleroma and sarcoidosis.

R L Modlin, F M Hofman, P R Meyer, O P Sharma, C R Taylor, T H Rea.   

Abstract

T lymphocyte subpopulations in frozen tissue sections of four granulomatous conditions (five patients with tuberculoid leprosy, five with lepromatous leprosy, seven with sarcoidosis and four with rhinoscleroma) were studied using monoclonal antibodies and a modified immunoperoxidase technique. Two immunohistological patterns were observed. In tuberculoid leprosy and sarcoidosis, lymphocytes expressing the helper/inducer phenotype were present within the aggregates of mononuclear phagocytes (epithelioid cells); however, cells with the suppressor/cytotoxic phenotype were predominantly in the lymphocytic mantle surrounding each granuloma. In lepromatous leprosy and rhinoscleroma the helper/inducer T cells and suppressor/cytotoxic T cells were both diffusely distributed among the mononuclear phagocytes (histiocytes) without any discernible mantle. The segregation of the helper/inducer and suppressor/cytotoxic phenotypic subsets was associated with an epithelioid cell differentiation of mononuclear phagocytic cells, bacterial elimination and a delayed type hypersensitivity response. The intimate admixture of helper/inducer and suppressor/cytotoxic subsets was associated with undifferentiated mononuclear phagocytes, bacterial proliferation and the absence of a delayed type hypersensitivity response. Thus the different distributions of T cell subpopulations in granulomas may be associated with differences in the host's immune response in several forms of granulomatous reactions.

Entities:  

Mesh:

Year:  1983        PMID: 6221839      PMCID: PMC1536790     

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  28 in total

1.  The granulomatous inflammatory response. A review.

Authors:  D O Adams
Journal:  Am J Pathol       Date:  1976-07       Impact factor: 4.307

Review 2.  Current concepts in the immunology of leprosy.

Authors:  T H Rea; N E Levan
Journal:  Arch Dermatol       Date:  1977-03

3.  Histological classification and the immunological spectrum of leprosy.

Authors:  D S Ridley
Journal:  Bull World Health Organ       Date:  1974       Impact factor: 9.408

4.  The effect of neonatal and adult thymectomy on the inflammatory response.

Authors:  T L Rothwell; W G Spector
Journal:  J Pathol       Date:  1972-09       Impact factor: 7.996

5.  Experimental lepromatous leprosy.

Authors:  R J Rees; M F Waters; A G Weddell; E Palmer
Journal:  Nature       Date:  1967-08-05       Impact factor: 49.962

6.  The inhibition of granuloma formation around Schistosoma mansoni eggs. II. Thymectomy.

Authors:  E O Domingo; K S Warren
Journal:  Am J Pathol       Date:  1967-11       Impact factor: 4.307

7.  The inhibition of granuloma formation around Schistosoma mansoni eggs. 3. Heterologous antilymphocyte serum.

Authors:  E O Domingo; K S Warren
Journal:  Am J Pathol       Date:  1968-03       Impact factor: 4.307

Review 8.  Immunological phenomena in leprosy and related diseases.

Authors:  J L Turk; A D Bryceson
Journal:  Adv Immunol       Date:  1971       Impact factor: 3.543

9.  Immunological identification of subpopulations of mononuclear cells in sarcoid granulomas.

Authors:  H Tannenbaum
Journal:  Ann N Y Acad Sci       Date:  1976       Impact factor: 5.691

10.  Granuloma formation around schistosome eggs as a manifestation of delayed hypersensitivity.

Authors:  K S Warren; E O Domingo; R B Cowan
Journal:  Am J Pathol       Date:  1967-11       Impact factor: 4.307

View more
  39 in total

1.  Comparison of the T cell patterns in leprous and cutaneous sarcoid granulomas. Presence of Valpha24-invariant natural killer T cells in T-cell-reactive leprosy together with a highly biased T cell receptor Valpha repertoire.

Authors:  M Mempel; B Flageul; F Suarez; C Ronet; L Dubertret; P Kourilsky; G Gachelin; P Musette
Journal:  Am J Pathol       Date:  2000-08       Impact factor: 4.307

Review 2.  T cell and cytokine patterns in leprosy skin lesions.

Authors:  P A Sieling; R L Modlin
Journal:  Springer Semin Immunopathol       Date:  1992

3.  Rhinoscleroma: a detailed histopathological diagnostic insight.

Authors:  Ahmed R H Ahmed; Zeinab H El-Badawy; Ibrahim R Mohamed; Waleed A M Abdelhameed
Journal:  Int J Clin Exp Pathol       Date:  2015-07-01

Review 4.  What makes granulomas tick?

Authors:  D G James
Journal:  Thorax       Date:  1991-10       Impact factor: 9.139

5.  T cell responses to mycobacterial catalase-peroxidase profile a pathogenic antigen in systemic sarcoidosis.

Authors:  Edward S Chen; Jan Wahlström; Zhimin Song; Matthew H Willett; Maria Wikén; Rex C Yung; Erin E West; John F McDyer; Ying Zhang; Anders Eklund; Johan Grunewald; David R Moller
Journal:  J Immunol       Date:  2008-12-15       Impact factor: 5.422

6.  The cellular composition of granulomas in mesenteric lymph nodes from patients with Crohn's disease.

Authors:  K Geboes; J van den Oord; C De Wolf-Peeters; V Desmet; P Rutgeerts; J Janssens; G Vantrappen; F Penninckx; R Kerremans
Journal:  Virchows Arch A Pathol Anat Histopathol       Date:  1986

Review 7.  Immune aspects of sarcoidosis.

Authors:  L W Poulter
Journal:  Postgrad Med J       Date:  1988-07       Impact factor: 2.401

Review 8.  Immunopathology of leprosy granulomas.

Authors:  R L Modlin; T H Rea
Journal:  Springer Semin Immunopathol       Date:  1988

9.  Differences in predominant T cell phenotypes and distribution pattern in reactional lesions of tuberculoid and lepromatous leprosy.

Authors:  R B Narayanan; S Laal; A K Sharma; L K Bhutani; I Nath
Journal:  Clin Exp Immunol       Date:  1984-03       Impact factor: 4.330

10.  Evidence of cells bearing interleukin-2 receptor at sites of disease activity in sarcoid patients.

Authors:  G Semenzato; C Agostini; L Trentin; R Zambello; M Chilosi; A Cipriani; E Ossi; M R Angi; L Morittu; G Pizzolo
Journal:  Clin Exp Immunol       Date:  1984-08       Impact factor: 4.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.